SI1560568T1 - Farmacevtski sestavki z nadzorovanim sproščanjem, ki vsebujejo natrijev alginat in natrijev-kalcijev alginat - Google Patents

Farmacevtski sestavki z nadzorovanim sproščanjem, ki vsebujejo natrijev alginat in natrijev-kalcijev alginat

Info

Publication number
SI1560568T1
SI1560568T1 SI200332359T SI200332359T SI1560568T1 SI 1560568 T1 SI1560568 T1 SI 1560568T1 SI 200332359 T SI200332359 T SI 200332359T SI 200332359 T SI200332359 T SI 200332359T SI 1560568 T1 SI1560568 T1 SI 1560568T1
Authority
SI
Slovenia
Prior art keywords
alginate
sodium
pharmaceutical compositions
controlled release
compositions containing
Prior art date
Application number
SI200332359T
Other languages
English (en)
Inventor
Robert Pisek
Andrejka Kramar
Franc Vrecer
Maja Kincl
Marjanca Breznik
Original Assignee
Krka, Tovarna Zdravil, D.D., Novo Mesto
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Krka, Tovarna Zdravil, D.D., Novo Mesto filed Critical Krka, Tovarna Zdravil, D.D., Novo Mesto
Publication of SI1560568T1 publication Critical patent/SI1560568T1/sl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SI200332359T 2002-10-08 2003-10-06 Farmacevtski sestavki z nadzorovanim sproščanjem, ki vsebujejo natrijev alginat in natrijev-kalcijev alginat SI1560568T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SI200200242A SI21300A (sl) 2002-10-08 2002-10-08 Farmacevtske formulacije z alginati
PCT/SI2003/000034 WO2004032904A1 (en) 2002-10-08 2003-10-06 Controlled release pharmaceutical compositions containing sodium alginate and sodium calcium alginate
EP03755718.8A EP1560568B1 (en) 2002-10-08 2003-10-06 Controlled release pharmaceutical compositions containing sodium alginate and sodium calcium alginate

Publications (1)

Publication Number Publication Date
SI1560568T1 true SI1560568T1 (sl) 2014-08-29

Family

ID=32091983

Family Applications (2)

Application Number Title Priority Date Filing Date
SI200200242A SI21300A (sl) 2002-10-08 2002-10-08 Farmacevtske formulacije z alginati
SI200332359T SI1560568T1 (sl) 2002-10-08 2003-10-06 Farmacevtski sestavki z nadzorovanim sproščanjem, ki vsebujejo natrijev alginat in natrijev-kalcijev alginat

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SI200200242A SI21300A (sl) 2002-10-08 2002-10-08 Farmacevtske formulacije z alginati

Country Status (9)

Country Link
EP (1) EP1560568B1 (sl)
AU (1) AU2003273212A1 (sl)
EA (1) EA007488B1 (sl)
HR (1) HRP20050312B1 (sl)
PL (1) PL208591B1 (sl)
RS (1) RS52818B (sl)
SI (2) SI21300A (sl)
UA (1) UA80990C2 (sl)
WO (1) WO2004032904A1 (sl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5367266B2 (ja) 2004-10-12 2013-12-11 エフエムシー バイオポリマー エイエス 自己ゲル化性アルギネート系及びその使用
WO2009032158A2 (en) 2007-08-28 2009-03-12 Fmc Corporation, Inc. Delayed self-gelling alginate systems and uses thereof
CN108853039B (zh) * 2018-08-07 2021-03-09 河北君临药业有限公司 一种克拉霉素分散片及其生产工艺

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE66143T1 (de) * 1985-01-11 1991-08-15 Abbott Lab Feste zubereitung mit langsamer freisetzung.
EP0275336A1 (de) * 1987-01-20 1988-07-27 Knoll Ag Arzneimittelzubereitung mit protahierender Wirkung
US5705190A (en) * 1995-12-19 1998-01-06 Abbott Laboratories Controlled release formulation for poorly soluble basic drugs
SI20108B (en) * 1997-06-11 2001-12-31 Abbott Lab A controlled release formulation for poorly soluble basic drugs

Also Published As

Publication number Publication date
PL374487A1 (en) 2005-10-31
EP1560568B1 (en) 2014-03-26
HRP20050312B1 (hr) 2014-09-26
HRP20050312A2 (en) 2006-02-28
UA80990C2 (en) 2007-11-26
RS52818B (sr) 2013-10-31
RS20050276A (en) 2007-06-04
EA007488B1 (ru) 2006-10-27
AU2003273212A1 (en) 2004-05-04
PL208591B1 (pl) 2011-05-31
WO2004032904A1 (en) 2004-04-22
EA200500613A1 (ru) 2005-10-27
EP1560568A1 (en) 2005-08-10
SI21300A (sl) 2004-04-30

Similar Documents

Publication Publication Date Title
IL160117A0 (en) Pulsatile release compositions and methods for enhanced gastrointestinal drug absorption
HUP0400384A3 (en) Benzamidine derivative and pharmaceutical compositions containing them and their use
HUS1400025I1 (hu) Feniletanolamin-származékok és az ezeket tartalmazó gyógyszerek
IL164987A0 (en) Proline derivatives and pharmaceutical compositions containing
HUP0303325A3 (en) Pharmaceutical salts and pharmaceutical compositions containing them
HUP0401333A3 (en) Spiropyrazole compounds and pharmaceutical compositions containing them
TWI319318B (en) Modified release pharmaceutical formulation
EP1424994A4 (en) PREPARATION OF A SUSTAINED RELEASE PHARMACEUTICAL COMPOSITION
EP1425019A4 (en) PHARMACEUTICAL COMPOSITION
SI1458377T1 (sl) Tegaserodovi farmacevtski sestavki
AU2003222921A8 (en) Novel perindopril salt and pharmaceutical compositions containing same
EP1411904A4 (en) PHARMACEUTICAL COMPOSITION WITH PROLONGED RELEASE
AU2003250372A8 (en) Pharmaceutical composition
IL176077A0 (en) 1-n-phenyl-amino-1h-imidazole derivatives and pharmaceutical compositions containing them
IL165069A0 (en) Immediate release pharmaceutical formulation
EP1501352A4 (en) METHOD AND COMPOSITIONS FOR PROTRACTED ACTIVE SUBSTANCE
EP1404301A4 (en) PHARMACEUTICAL COMPOSITIONS WITH CONTROLLED RELEASE, STABLE, CONTAINING PRAVASTATIN
SI1560568T1 (sl) Farmacevtski sestavki z nadzorovanim sproščanjem, ki vsebujejo natrijev alginat in natrijev-kalcijev alginat
HK1081451A1 (en) Medicinal composition
GB2406517B (en) Minocycline controlled release pharmaceutical composition
HK1062274A1 (en) Medicinal composition
AU2003258772A8 (en) Novel neutracetical and pharmaceutical compositions and their uses
AU2002236132A1 (en) Modified release oral pharmaceutical composition
EP1547593A4 (en) MEDICINAL COMPOSITION
AU2003288588A1 (en) An extended release pharmaceutical composition of phenytoin sodium